1 January 2011 in Pathogens and Global Health
Hendra virus (HeV) was first isolated in 1994, from a disease outbreak involving at least 21 horses and two humans in the Brisbane suburb of Hendra, Australia. The affected horses and humans all developed a severe but unidentified respiratory disease that resulted in the deaths of one of the human cases and the deaths or putting down of 14 of the horses. The virus, isolated by culture from a horse and the kidney of the fatal human case, was initially characterised as a new member of the genus Morbillivirus in the family Paramyxoviridae. Comparative sequence analysis of part of the matrix protein gene of the virus and the discovery that the virus had an exceptionally large genome subsequently led to HeV being assigned to a new genus, Henipavirus, along with Nipah virus (a newly emergent virus in pigs). The regular outbreaks of HeV-related disease that have occurred in Australia since 1994 have all been characterised by acute respiratory and neurological manifestations, with high levels of morbidity and mortality in the affected horses and humans. The modes of transmission of HeV remain largely unknown. Although fruit bats have been identified as natural hosts of the virus, direct bat-horse, bat-human or human-human transmission has not been reported. Human infection can occur via exposure to infectious urine, saliva or nasopharyngeal fluid from horses. The treatment options and efficacy are very limited and no vaccine exists. Reports on the outbreaks of HeV in Australia are collated in this review and the available data on the biology, transmission and detection of the pathogen are summarized and discussed.
17 October 2024 in Wellcome Open Research
The Avian Contact Study is a cross-sectional questionnaire of poultry workers and other individuals who have contact with domestic and/or wild birds in the UK. The questionnaire was launched online in May 2024 and in-person responses were gathered at the British Pig and Poultry Fair in Birmingham on 15 and 16 May 2024. This Data Note documents questionnaire development, content and delivery methods. Data collected include information on demographics, seasonal influenza vaccination, avian influenza exposure, contact with birds and people, and awareness of avian influenza. This Data Note provides insights into the first data release collected up to 31 July 2024 for 225 respondents. Data have been released as a University of Bristol held dataset available upon request. The Avian Contact Study provides a pilot resource for research into avian influenza from a zoonotic perspective.
19 April 2025 in Influenza and Other Respiratory Viruses
Background: Following the 2021–2022 avian influenza panzootic in birds and wildlife, seasonal influenza vaccines have been advised to occupationally high‐risk groups to reduce the likelihood of coincidental infection in humans with both seasonal and avian influenza A viruses.Methods: We developed and launched a questionnaire aimed at poultry workers and people in direct contact with birds to understand awareness and uptake of seasonal influenza vaccination. We collected responses in‐person at an agricultural trade event and online.Findings: The questionnaire was completed by 225 individuals from across the United Kingdom. The most commonly reported reason for vaccination was protection against seasonal influenza (82%, 63 of 77). Nearly, all individuals aged ≥65 years reported that the vaccine was recommended for them (24 of 28). There was no difference in recommendation for occupational groups. Most vaccinees were aged over 60 years (60%, 29 of 48); however, coverage was lower than expected in the ≥ 65 target group. Vaccination in those exposed to avian influenza was low (32%, 9 of 28). Not having enough time was the single most reported reason for not getting vaccinated in those intending to. Individuals unintending to be vaccinated perceived natural immunity to be better than receiving the vaccine as well as lack of awareness and time.Conclusions: Our findings suggest that targeted campaigns in occupationally exposed groups need to be undertaken to improve communication of information and access to vaccine clinics. We recommend co‐production methods to optimise this public health strategy for increased knowledge and future vaccine uptake.